Kohei Somekawa

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis.

Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis.

Journal: Anticancer research
Published: April 21, 2026

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.

Journal: Genes
Published: August 22, 2025

Insights into the effects of inhaled drugs on airway epithelium with human airway basal cells.

Insights into the effects of inhaled drugs on airway epithelium with human airway basal cells.

Journal: Biochemical and biophysical research communications
Published: July 28, 2025

Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic review.

Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic review.

Journal: European respiratory review : an official journal of the European Respiratory Society
Published: February 19, 2025

Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study.

Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study.

Journal: Translational lung cancer research
Published: February 13, 2025

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Translational lung cancer research
Published: January 30, 2025

Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study.

Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study.

Journal: Translational lung cancer research
Published: August 29, 2024

The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids.

The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids.

Journal: Genes
Published: August 29, 2024

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.

Journal: European clinical respiratory journal
Published: July 30, 2024

HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia.

HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia.

Journal: HLA
Published: February 26, 2024

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse.

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse.

Journal: PloS one
Published: February 15, 2024

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Journal: Thoracic cancer
Published: February 02, 2024
Showing 1-12 of 29

Last Updated: 09/26/2026